Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you take anticoagulants such as warfarin or a direct oral anticoagulant and you're considering Wegovy (semaglutide), the short answer is: there is no blanket clinical rule that makes the combination impossible, but there are real interactions worth understanding before you start. Wegovy is a prescription-only medicine and every decision about combining it with existing medication rests with a prescriber who reviews your full medical picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, and this is the interaction that clinical guidance singles out most clearly. Warfarin is a narrow-therapeutic-index medicine, meaning small shifts in its absorption or metabolism can push your INR outside the target range in either direction. Semaglutide slows the movement of food and other substances through the stomach (a property called delayed gastric emptying) and that slowing can subtly change how quickly an oral warfarin dose is absorbed.
The practical consequence is that your INR may drift upward or downward when you start Wegovy, or when your dose is increased during titration. The Wegovy Summary of Product Characteristics (SmPC), available through the electronic Medicines Compendium, lists warfarin as a specific interaction requiring close monitoring. That is not a reason to rule out the combination; it is a reason to plan for it. If you are managed by an anticoagulation clinic, tell them you are starting or changing a GLP-1 medicine so they can schedule additional INR checks around each dose step.
The interaction tends to be most pronounced in the first few weeks of treatment and around each titration point rather than during stable maintenance dosing, though this varies between individuals. Worth noting for context: people who want to know whether they can give blood while on Wegovy are in a different category to those on therapeutic anticoagulation, separate guidance covers blood donation on Wegovy.
Direct oral anticoagulants do not require the same routine INR monitoring as warfarin because they have more predictable pharmacokinetics. The gastric-emptying effect of semaglutide is still present, but the clinical significance for DOACs is considered lower than for warfarin. None of the four main DOACs used in the UK is listed as a specific named interaction in the Wegovy SmPC in the same way warfarin is.
That said, lower risk is not the same as no risk. If you start Wegovy and notice unusual bruising, bleeding that takes longer than expected to stop, or any other change in how your body responds, tell your prescriber promptly. The NHS semaglutide medicines page advises checking with a pharmacist or GP before starting any new medicine alongside semaglutide, that applies in both directions, so if your anticoagulation is being managed by a specialist team, loop them in rather than waiting for a routine appointment.
One practical detail that sometimes gets missed: dabigatran (Pradaxa) is absorbed by a mechanism partly dependent on stomach acid. Semaglutide's gastric-emptying effect could theoretically alter this, though evidence specific to the combination is limited. If your anticoagulant is dabigatran, mention it explicitly when your prescriber reviews your medication history.
Not automatically. For most people on a DOAC, the interaction profile is manageable with straightforward communication between care teams. For people on warfarin, the combination is also used clinically, it just asks more of the monitoring system around you. The key is that your prescriber needs a complete picture before they approve treatment.
At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber, not processed by software. Your current medication list (including any anticoagulants) is part of what the prescriber reads before reaching a decision. If you are thinking about cost alongside clinical fit, our Wegovy price comparison page sets out what private treatment typically involves.
There is a separate but related question some people ask: does semaglutide itself thin the blood? The evidence on that is worth understanding clearly, and this page on whether semaglutide thins the blood covers it properly. It is not an anticoagulant, which matters for how you think about the interaction in the other direction too.
Be specific. Don't just mention that you're on a blood thinner; name the medicine, the dose, and who manages it, your GP, a cardiology team, an anticoagulation clinic, or a combination. If your INR target range is narrow (common in people with mechanical heart valves, for instance), say so. Prescribers find it easier to plan monitoring schedules when they know the full picture upfront.
A few other things worth mentioning in the same conversation: any recent bleeding episodes, any changes to your diet that might already be affecting your INR, and whether you are on any other medicines that interact with anticoagulants. Wegovy is titrated slowly (starting at a low dose and increasing over months) and each titration step is a logical point to check in with your anticoagulation team if you are on warfarin.
The beginner's guide to Wegovy covers the titration schedule and what to expect from the first pen, which can help you time those anticoagulation check-ins sensibly. And if a friend or family member has asked whether they can take semaglutide alongside blood thinners, the answer depends just as much on which anticoagulant they're taking, the weight loss treatments overview is a useful starting point for their own clinical conversation.
Speak to our prescribers through a free consultation, and we'll review your medication list, including any anticoagulants, the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.